American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Goals for chronic myeloid leukemia TK inhibitor treatment: How little disease is too much?
    Journal Article

    Mauro, M. J.
    Hematology-American Society of Hematology Education Program (2014)

    Fulltext@MSK | Save
  • The safety and activity of BMS-906024, a gamma secretase inhibitor (GSI) with anti-Notch activity, in patients with relapsed T-cell acute lymphoblastic leukemia (T-ALL): Initial results of a phase 1 trial
    Meeting Abstract

    Zweidler-McKay, P. A.; DeAngelo, D. J.; Douer, D.; Dombret, H.; Ottmann, O. G.; Vey, N.; Thomas, D. A.; Zhu, L. L.; Huang, F.; Bajaj, G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High body mass index (BMI) in North American elderly diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab (R)-CHOP compensates for negative impact of male gender
    Meeting Abstract

    Zhou, Z.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Crosby-Thompson, A.; Vanderplas, A.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; Kaminski, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A phase 2 study of idelalisib monotherapy in previously untreated patients >= 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Zelenetz, A. D.; Lamanna, N.; Kipps, T. J.; Coutre, S. E.; O'Brien, S.; Aiello, M.; Cho, Y.; Dubowy, R. L.; Flinn, I. W.
    Blood (2014)

    Fulltext@MSK | Save
  • An open-label phase II study of buparlisib (BKM120) in patients with relapsed and refractory diffuse large B-cell lymphoma, mantle cell lymphoma or follicular ymphoma
    Meeting Abstract

    Younes, A.; Salles, G.; Bociek, R. G.; Martinelli, G.; Caballero, D.; Barca, E. G.; Mukherjee, N.; Williams, L.; Herbst, F.; Tavorath, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Structure-guided design of DOT1L methyltransferase inhibitors by a novel, label free assay platform
    Meeting Abstract

    Yi, J. S.; Federation, A.; Qi, J.; Dhe-Paganon, S.; Hadler, M.; Xu, X.; Varca, A.; St Pierre, R.; Armstrong, S. A.; Bradner, J. E.
    Blood (2014)

    Fulltext@MSK | Save
  • RUNX1/CBFβ dosage is critical for MLL leukemias development
    Meeting Abstract

    Yan, X. M.; Hayashi, Y.; Zhao, X. H.; Chen, A. L.; Zhang, Y.; He, F. H.; Dong, Y. Z.; Rao, Y. L.; Li, B.; Conway, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Microrna mediated regulation of hematopoietic stem cell aging
    Meeting Abstract

    Yalcin, S.; Carty, M.; Shin, J. Y.; Miller, R. A.; Leslie, C.; Park, C. Y.
    Blood (2014)

    Fulltext@MSK | Save
  • Role of p21 in a mouse model of NUP98-HOXD13 fusion driven myelodysplastic syndromes (MDS)
    Meeting Abstract

    Xu, H. M.; Deblasio, T. R.; Armstrong, S. A.; Nimer, S.
    Blood (2014)

    Fulltext@MSK | Save
  • CC-486 (oral azacitidine) following allogeneic hematopoietic stem cell transplantation (AlloHSCT) in patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)
    Meeting Abstract

    William, B. M.; de Lima, M.; Oran, B.; Champlin, R.; Papadopoulos, E. B.; Giralt, S.; Scott, B. L.; Hetzer, J.; Wang, X. W.; Laille, E.; more...
    Blood (2014)

    Fulltext@MSK | Save